SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-004305
Filing Date
2016-03-23
Accepted
2016-03-23 16:10:37
Documents
3
Period of Report
2016-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20160323x8k.htm 8-K 36863
2 EX-99.1 acrs-20160323ex991439bc5.htm EX-99.1 147424
3 GRAPHIC acrs20160323ex991439bc5001.jpg GRAPHIC 759489
  Complete submission text file 0001558370-16-004305.txt   1212608
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 161524039
SIC: 2834 Pharmaceutical Preparations